Supplementary Figure S3 from Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib Article Swipe
Nicolás A. Fraunhoffer
,
Analía Meilerman Abuelafia
,
Martin Bigonnet
,
Odile Gayet
,
Julie Roques
,
Emmanuel Telle
,
Patricia Santofimia‐Castaño
,
María Teresa Borrello
,
Eduardo Chuluyán
,
Nelson Dusetti
,
Juan Iovanna
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.22477715.v1
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.22477715.v1
Supplementary Figure S3
Related Topics
Concepts
Carfilzomib
Pancreatic ductal adenocarcinoma
Proteasome inhibitor
Medicine
Internal medicine
Oncology
Cancer research
Pancreatic cancer
Multiple myeloma
Cancer
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/1078-0432.22477715.v1
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4361937615
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4361937615Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/1078-0432.22477715.v1Digital Object Identifier
- Title
-
Supplementary Figure S3 from Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor CarfilzomibWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-03-31Full publication date if available
- Authors
-
Nicolás A. Fraunhoffer, Analía Meilerman Abuelafia, Martin Bigonnet, Odile Gayet, Julie Roques, Emmanuel Telle, Patricia Santofimia‐Castaño, María Teresa Borrello, Eduardo Chuluyán, Nelson Dusetti, Juan IovannaList of authors in order
- Landing page
-
https://doi.org/10.1158/1078-0432.22477715.v1Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/1078-0432.22477715.v1Direct OA link when available
- Concepts
-
Carfilzomib, Pancreatic ductal adenocarcinoma, Proteasome inhibitor, Medicine, Internal medicine, Oncology, Cancer research, Pancreatic cancer, Multiple myeloma, CancerTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4361937615 |
|---|---|
| doi | https://doi.org/10.1158/1078-0432.22477715.v1 |
| ids.doi | https://doi.org/10.1158/1078-0432.22477715.v1 |
| ids.openalex | https://openalex.org/W4361937615 |
| fwci | |
| type | preprint |
| title | Supplementary Figure S3 from Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10231 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9850999712944031 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | Pancreatic and Hepatic Oncology Research |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2780108899 |
| concepts[0].level | 4 |
| concepts[0].score | 0.9852550625801086 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q15366934 |
| concepts[0].display_name | Carfilzomib |
| concepts[1].id | https://openalex.org/C2992026798 |
| concepts[1].level | 4 |
| concepts[1].score | 0.8271878361701965 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q212961 |
| concepts[1].display_name | Pancreatic ductal adenocarcinoma |
| concepts[2].id | https://openalex.org/C2778367456 |
| concepts[2].level | 3 |
| concepts[2].score | 0.5773320198059082 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q7251235 |
| concepts[2].display_name | Proteasome inhibitor |
| concepts[3].id | https://openalex.org/C71924100 |
| concepts[3].level | 0 |
| concepts[3].score | 0.43007558584213257 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[3].display_name | Medicine |
| concepts[4].id | https://openalex.org/C126322002 |
| concepts[4].level | 1 |
| concepts[4].score | 0.419106662273407 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[4].display_name | Internal medicine |
| concepts[5].id | https://openalex.org/C143998085 |
| concepts[5].level | 1 |
| concepts[5].score | 0.36845874786376953 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[5].display_name | Oncology |
| concepts[6].id | https://openalex.org/C502942594 |
| concepts[6].level | 1 |
| concepts[6].score | 0.3644934296607971 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[6].display_name | Cancer research |
| concepts[7].id | https://openalex.org/C2780210213 |
| concepts[7].level | 3 |
| concepts[7].score | 0.18018049001693726 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q212961 |
| concepts[7].display_name | Pancreatic cancer |
| concepts[8].id | https://openalex.org/C2776364478 |
| concepts[8].level | 2 |
| concepts[8].score | 0.11743798851966858 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q467635 |
| concepts[8].display_name | Multiple myeloma |
| concepts[9].id | https://openalex.org/C121608353 |
| concepts[9].level | 2 |
| concepts[9].score | 0.09182435274124146 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[9].display_name | Cancer |
| keywords[0].id | https://openalex.org/keywords/carfilzomib |
| keywords[0].score | 0.9852550625801086 |
| keywords[0].display_name | Carfilzomib |
| keywords[1].id | https://openalex.org/keywords/pancreatic-ductal-adenocarcinoma |
| keywords[1].score | 0.8271878361701965 |
| keywords[1].display_name | Pancreatic ductal adenocarcinoma |
| keywords[2].id | https://openalex.org/keywords/proteasome-inhibitor |
| keywords[2].score | 0.5773320198059082 |
| keywords[2].display_name | Proteasome inhibitor |
| keywords[3].id | https://openalex.org/keywords/medicine |
| keywords[3].score | 0.43007558584213257 |
| keywords[3].display_name | Medicine |
| keywords[4].id | https://openalex.org/keywords/internal-medicine |
| keywords[4].score | 0.419106662273407 |
| keywords[4].display_name | Internal medicine |
| keywords[5].id | https://openalex.org/keywords/oncology |
| keywords[5].score | 0.36845874786376953 |
| keywords[5].display_name | Oncology |
| keywords[6].id | https://openalex.org/keywords/cancer-research |
| keywords[6].score | 0.3644934296607971 |
| keywords[6].display_name | Cancer research |
| keywords[7].id | https://openalex.org/keywords/pancreatic-cancer |
| keywords[7].score | 0.18018049001693726 |
| keywords[7].display_name | Pancreatic cancer |
| keywords[8].id | https://openalex.org/keywords/multiple-myeloma |
| keywords[8].score | 0.11743798851966858 |
| keywords[8].display_name | Multiple myeloma |
| keywords[9].id | https://openalex.org/keywords/cancer |
| keywords[9].score | 0.09182435274124146 |
| keywords[9].display_name | Cancer |
| language | en |
| locations[0].id | doi:10.1158/1078-0432.22477715.v1 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/1078-0432.22477715.v1 |
| locations[1].id | pmh:oai:figshare.com:article/22477715 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S4306400572 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | OPAL (Open@LaTrobe) (La Trobe University) |
| locations[1].source.host_organization | https://openalex.org/I196829312 |
| locations[1].source.host_organization_name | La Trobe University |
| locations[1].source.host_organization_lineage | https://openalex.org/I196829312 |
| locations[1].license | cc-by |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | https://openalex.org/licenses/cc-by |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | https://figshare.com/articles/journal_contribution/Supplementary_Figure_S3_from_Evidencing_a_Pancreatic_Ductal_Adenocarcinoma_Subpopulation_Sensitive_to_the_Proteasome_Inhibitor_Carfilzomib/22477715 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5045888426 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-1561-2563 |
| authorships[0].author.display_name | Nicolás A. Fraunhoffer |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Nicolas A. Fraunhoffer |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5084835361 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Analía Meilerman Abuelafia |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Analía Meilerman Abuelafia |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5045355441 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-5652-3132 |
| authorships[2].author.display_name | Martin Bigonnet |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Martin Bigonnet |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5004923572 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-8635-3648 |
| authorships[3].author.display_name | Odile Gayet |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Odile Gayet |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5064568532 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Julie Roques |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Julie Roques |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5083020234 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Emmanuel Telle |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Emmanuel Telle |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5018793588 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-2506-5567 |
| authorships[6].author.display_name | Patricia Santofimia‐Castaño |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Patricia Santofimia-Castaño |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5056661555 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-1365-1358 |
| authorships[7].author.display_name | María Teresa Borrello |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | María Teresa Borrello |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5013355210 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-3084-2500 |
| authorships[8].author.display_name | Eduardo Chuluyán |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Eduardo Chuluyan |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5002621255 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-6161-8483 |
| authorships[9].author.display_name | Nelson Dusetti |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Nelson Dusetti |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5066948009 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-1822-2237 |
| authorships[10].author.display_name | Juan Iovanna |
| authorships[10].author_position | last |
| authorships[10].raw_author_name | Juan Iovanna |
| authorships[10].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/1078-0432.22477715.v1 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Supplementary Figure S3 from Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10231 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9850999712944031 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | Pancreatic and Hepatic Oncology Research |
| related_works | https://openalex.org/W4361889071, https://openalex.org/W4361937741, https://openalex.org/W4361889016, https://openalex.org/W4361937708, https://openalex.org/W4361889062, https://openalex.org/W4361888922, https://openalex.org/W4361937761, https://openalex.org/W4361888893, https://openalex.org/W4361889052, https://openalex.org/W4361937615 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1158/1078-0432.22477715.v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/1078-0432.22477715.v1 |
| primary_location.id | doi:10.1158/1078-0432.22477715.v1 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/1078-0432.22477715.v1 |
| publication_date | 2023-03-31 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.Figure | 1 |
| abstract_inverted_index.S3</p> | 2 |
| abstract_inverted_index.<p>Supplementary | 0 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 11 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/2 |
| sustainable_development_goals[0].score | 0.46000000834465027 |
| sustainable_development_goals[0].display_name | Zero hunger |
| citation_normalized_percentile.value | 0.16084091 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |